MACI · Melar Acquisition Corp. I/Cayman
$10.98
At close · Sep 4
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The working capital deficit and the expectation of significant future costs raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements are issued. Additionally, Management has determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination by the end of the Combination Period, raises substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 20, 2026. Management plans to address this uncertainty through the closing of its proposed Business Combination. There is no assurance that the Company's plans to consummate a Business Combination will be successful within the Combination Period. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$104.81M
Shares
9.55M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.98
Open$10.99
Day$10.98–10.99
52W close$10.50–10.99
Avg vol 30d2K
Short int9K · 0.1% float · 23.4d
Short vol94%
DataJul 2024–Sep 2026
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
$3.90M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
26.9
Trailing earnings · reciprocal yield 3.7%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$2,068
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+4.4%
Trailing year
Short interest
0.1%
Latest settlement · 23.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 14.5 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
+1%
above
RSI (14)
59
neutral
MACD trend
Negative
52-week position
98%
near high
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+3%
trailing
YTD return
+3%
this year
Relative strength
−12%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Distributing
-23% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.09% of float · ▲ +60.9% MoM · 23.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
40 holders — near 2-yr low, contrarian setup
Squeeze score
70
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
4%
annualized · 1-yr
Max drawdown
−2%
past year
ATR
0.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
59
Neutral
MACD trend
Negative
Bearish
52-week position
98%
Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow
Distributing
-23% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.09% of float · ▲ +60.9% MoM · 23.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
40 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $11
Now $11 · 98%
Range high $11
vs 200-day avg +3%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MACI
this stock
Melar Acquisition Corp. I/Cayman
|
$104.81M | +3.3% | — | — | 0.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$746.38M | — | — | — | 6.0% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$647.83M | +2.7% | — | — | 0.2% |
|
BCSS
Bain Capital GSS Investment Corp.
|
$602.40M | +2.3% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MACI | +0.3% | +0.6% | +3.5% | +0.3% | +3.3% |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | +0.2% | +1.0% | -11.6% | -0.1% | -9.7% |
Key facts
CIK
2016221
CUSIP
G6004G100
13F (30d)
14 filings
14 filers
Visit website
Investor relations